Cost-effectiveness of ablation of ventricular tachycardia in ischaemic cardiomyopathy: limitations in the trial evidence base

OBJECTIVE: Catheter ablation is an important treatment for ventricular tachycardia (VT) that reduces the frequency of episodes of VT. We sought to evaluate the cost-effectiveness of catheter ablation versus antiarrhythmic drug (AAD) therapy. METHODS: A decision-analytic Markov model was used to calc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Gomes, Manuel, Garcia, Jason V, Hunter, Ross J, Chow, Anthony W, Dhinoja, Mehul, Schilling, Richard J, Lowe, Martin, Lambiase, Pier D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Care Delivery, Economics and Global Health Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999675/
https://www.ncbi.nlm.nih.gov/pubmed/32076562
http://dx.doi.org/10.1136/openhrt-2019-001155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999675/
https://www.ncbi.nlm.nih.gov/pubmed/32076562
http://dx.doi.org/10.1136/openhrt-2019-001155

Ejemplares similares